Stephan Thijssen

This inventor holds 29 USPTO granted patents and 11 published patent applications, plus 8 CIPO patents and 14 EPO patents, primarily in Dialysis Technologies. Top assignee: Fresenius Medical Care Holdings, Inc.. Active years: 2013-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stephan Thijssen. Retrieved from https://idiyas.com/inventor/stephan-thijssen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 29 (Patent Applications = 11)

% Patents Active = 96.6

CIPO Patents = 8 (Patent Applications = 8)

EPO Patents = 14 (Patent Applications = 21)

Average Co-Inventor Count = 3.8

ph-index = 4

Forward Citations = 105(Granted Patents)

Company Filing History:

29 out of 672

Fresenius Medical Care Holdings, Inc.

patents

Years Active: 2013-2026

Loading Chart...

Areas of Expertise:

Dialysis

Patient Profiling

Toxin Displacers

Vascular Access

Clinical Trials

Hemodynamic Monitoring

Erythropoiesis

Cardiac Output

Anticoagulation

Blood Characteristics

Access Recirculation

Ultrafiltration

29 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12623013 - COMPOUNDS, SYSTEMS, AND TECHNIQUES FOR REMOVAL OF PERIPHERAL AMYLOID BETA PEPTIDE WITH ALBUMIN BINDING COMPETITORS (2026-05-12),

2. 12597482 - Techniques for modelling and optimizing dialysis toxin displacer compounds (2026-04-07),

3. 12472291 - Techniques for determining dialysis patient profiles (2025-11-18),

4. 12343464 - Techniques for determining dialysis patient profiles (2025-07-01),

5. 12228564 - Systems and methods for analyzing spent dialysate (2025-02-18),

6. 12226563 - Vascular access identification and validation system (2025-02-18),

7. 12106831 - Techniques for conducting virtual clinical trials (2024-10-01),

8. 12036344 - Systems and methods for analyzing spent dialysate (2024-07-16),

9. 11878098 - System for analyzing vascular refill during short-pulse ultrafiltration in hemodialysis (2024-01-23),

10. 11744930 - Intradialytic monitoring of hemodynamic status based on detection of oxygen signature phase shift (2023-09-05),

11. 11640846 - Techniques for modelling and optimizing dialysis toxin displacer compounds (2023-05-02),

12. 11623032 - Techniques for determining patient blood characteristics during a dialysis process (2023-04-11),

13. 11565028 - Techniques for non-invasive determination of estimated cardiac output during dialysis treatment (2023-01-31),

14. 11426503 - Arteriovenus fistula maturation monitoring systems and methods (2022-08-30),

15. 11419966 - Virtual patient donation (2022-08-23),

As an AI assistant specializing in innovations, inventions, inventors, patent attorneys, assignees, and patents, I would like to introduce you to the accomplished inventor Stephan Thijssen from New York, NY.

Title: The Innovative Mind of Stephan Thijssen

Introduction: Stephan Thijssen, a prolific inventor based in New York, has made significant contributions to the field of medical technology with a total of 22 patents to his name.

Latest Patents:

1. **Systems and Methods for Analyzing Spent Dialysate:** Stephan's inventive apparatus for analyzing spent dialysate involves a unique configuration of surfaces to accommodate a dialysate drain bag or drain line, a strategically positioned light source, and a light sensor to sense emitted light, enhancing the efficiency of dialysis procedures.

2. **System for Analyzing Vascular Refill during Short-Pulse Ultrafiltration in Hemodialysis:** His method for analyzing vascular refill during hemodialysis revolutionizes patient care by utilizing a vascular refill model to estimate hemodialysis treatment-related parameters and determine appropriate treatment operations, ultimately improving patient outcomes significantly.

Career Highlights: Stephan Thijssen is a valued member of Fresenius Medical Care Holdings, Inc., a renowned medical technology company dedicated to enhancing the quality of life for patients worldwide.

Collaborations: He collaborates closely with esteemed colleagues like Peter Kotanko and Nathan W Levin, forming a dynamic team at Fresenius Medical Care Holdings, Inc., to drive innovation and advancements in the medical technology sector.

Conclusion: Stephan Thijssen's ingenuity and dedication to improving medical technology through his groundbreaking inventions have solidified his reputation as a visionary inventor in the field. His work continues to have a profound impact on the healthcare industry, setting new standards for excellence in patient care and treatment outcomes.

Profile summary based on public USPTO records.